Caspase-11-mediated Endothelial Pyroptosis Underlies Endotoxemia-induced Lung Injury
Overview
Authors
Affiliations
Acute lung injury is a leading cause of death in bacterial sepsis due to the wholesale destruction of the lung endothelial barrier, which results in protein-rich lung edema, influx of proinflammatory leukocytes, and intractable hypoxemia. Pyroptosis is a form of programmed lytic cell death that is triggered by inflammatory caspases, but little is known about its role in EC death and acute lung injury. Here, we show that systemic exposure to the bacterial endotoxin lipopolysaccharide (LPS) causes severe endothelial pyroptosis that is mediated by the inflammatory caspases, human caspases 4/5 in human ECs, or the murine homolog caspase-11 in mice in vivo. In caspase-11-deficient mice, BM transplantation with WT hematopoietic cells did not abrogate endotoxemia-induced acute lung injury, indicating a central role for nonhematopoietic caspase-11 in endotoxemia. Additionally, conditional deletion of caspase-11 in ECs reduced endotoxemia-induced lung edema, neutrophil accumulation, and death. These results establish the requisite role of endothelial pyroptosis in endotoxemic tissue injury and suggest that endothelial inflammatory caspases are an important therapeutic target for acute lung injury.
New insights into the noncanonical inflammasome point to caspase-4 as a druggable target.
Elkayam E, Gervais F, Wu H, A Crackower M, Lieberman J Nat Rev Immunol. 2025; .
PMID: 40044809 DOI: 10.1038/s41577-025-01142-9.
GSDMD-mediated pyroptosis: molecular mechanisms, diseases and therapeutic targets.
Li Y, Guo B Mol Biomed. 2025; 6(1):11.
PMID: 39994107 PMC: 11850691. DOI: 10.1186/s43556-025-00249-8.
The role of programmed cell death in organ dysfunction induced by opportunistic pathogens.
Wang Y, Weng L, Wu X, Du B Crit Care. 2025; 29(1):43.
PMID: 39856779 PMC: 11761187. DOI: 10.1186/s13054-025-05278-x.
Cao C, Memete O, Dun Y, Zhang L, Liu F, He D Stem Cell Res Ther. 2025; 16(1):13.
PMID: 39849583 PMC: 11756119. DOI: 10.1186/s13287-024-04124-1.
Dual alarmin-receptor-specific targeting peptide systems for treatment of sepsis.
Mun S, Cho E, Gil W, Kim S, Kim H, Ham Y Acta Pharm Sin B. 2025; 14(12):5451-5463.
PMID: 39807314 PMC: 11725134. DOI: 10.1016/j.apsb.2024.08.015.